Double-blind, randomized, steroid-controlled, parallel-group study of GGS in patients with optic neuritis (ON) (Phase 3 study)
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Immune globulin (Primary) ; Methylprednisolone sodium succinate
- Indications Optic neuritis
- Focus Therapeutic Use
- Sponsors Teijin Pharma
- 19 Jun 2018 Status changed from recruiting to completed.
- 01 May 2017 Planned End Date changed from 30 Nov 2015 to 31 Aug 2018.
- 09 Jun 2016 New trial record